ARTICLE | Clinical News
Beposone: Phase II data
May 14, 2012 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase II trial in about 600 patients aged 12 and older with allergic rhinitis due to Mountain Cedar pollen showed that twice-daily Beposone nasal spray signific...